Pgiam/iStock via Getty Images
A lot has happened over at TG Therapeutics, Inc. (NASDAQ:TGTX) in the one month since my coverage in March. In chronological order, these are - positive opinion from the CHMP in Europe, sales data from Symphony Health cited
About the TPT service
Thanks for reading. At the Total Pharma Tracker, we offer the following:-
Our Android app and website features a set of tools for DIY investors, including a work-in-progress software where you can enter any ticker and get extensive curated research material.
For investors requiring hands-on support, our in-house experts go through our tools and find the best investible stocks, complete with buy/sell strategies and alerts.
Sign up now for our free trial, request access to our tools, and find out, at no cost to you, what we can do for you.
